Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT07600008
EARLY_PHASE1

Development of a Preparation for Supportive Supplementation of Probiotics in Patients With Reflux

Sponsor: University Hospital Olomouc

View on ClinicalTrials.gov

Summary

A two-arm, double-blind, randomized, placebo-controlled study investigating the efficacy of a probiotic preparation developed as supportive supplementation of probiotics in patients with reflux. The objective of this trial is to evaluate the effect of the probiotic dietary supplement on the diversity and composition of the gut microbiome in patients diagnosed with GERD who are on PPI therapy. The study will also monitor changes in the oral microbiome and the impact of probiotic supplementation on patient quality of life and GERD symptoms. Patients will take the probiotic preparation, 2 tablets twice daily (morning before meals and evening after meals). The experimental phase will last 6 weeks. Patients in the control arm will receive placebo. Supplementation will be discontinued if adverse effects occur. Oral and rectal swabs will be taken before and after administration of the preparation. Patients will monitor their symptoms using a questionnaire.

Key Details

Gender

All

Age Range

40 Years - 55 Years

Study Type

INTERVENTIONAL

Enrollment

50

Start Date

2026-01-15

Completion Date

2026-07-30

Last Updated

2026-05-20

Healthy Volunteers

No

Interventions

DIETARY_SUPPLEMENT

A probiotic dietary supplement

A probiotic dietary supplement containing a blend of probiotic bacteria from the Lactobacillaceae family, and the genera Streptococcus and Bifidobacterium, selected based on the latest knowledge concerning the use of probiotics in relation to GERD.

DIETARY_SUPPLEMENT

Placebo

placebo with the same appearance as the probiotic supplement

Locations (1)

University Hospital Olomouc

Olomouc, Czechia